University of Arkansas
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Arkansas sits in the top decile of US sponsors by registered trial count (#113 of 15,742 sponsors by registered trial count).
University of Arkansas: 318 sponsored US clinical trials, 37 recruiting.
University of Arkansas sponsors 318 registered US clinical trials on ClinicalTrials.gov, 37 of them currently recruiting, and 202 completed. 17 of these trials are in Phase 3-4 (later-stage) and 102 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Myeloma, with 15 trials.
Top-decile sponsor footprint
University of Arkansas ranks in the top decile of sponsors by registered trial count (#113 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
202 of 262 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
318 total, page 4 of 7
A Physical Activity Program in End-state Liver Disease
NCT02776553
Reducing Depressive Symptoms Among Rural African Americans
NCT02860741
Bupropion for Depression in ESRD Patients on Hemodialysis
NCT02238977
Motivated Behavior in Adults With and Without ADHD
NCT02630017
Improving Treatment Outcomes for Prescription Opioid Dependence
NCT02543944
Neuropathic Pain in Pregnancy
NCT02608463
Pilot Study: Rectus Sheath Blocks for Improving Abdominal Surgery Conditions
NCT02447965
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
NCT02481414
UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment
NCT02499081
Real-time fMRI and Neurofeedback of Brain Networks Mediating Trauma Memory Recall in PTSD
NCT02500719
A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
NCT02485964
Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis
NCT02389127
Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)
NCT02365909
Family Model of Diabetes Self-Management Education in the Marshallese Community
NCT02407132
UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus
NCT02192775
Vaccination of High Risk Breast Cancer Patients
NCT02229084
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
NCT01979003
A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema
NCT02020837
The Effects of ProFoveate on Reducing Self-Stimulating Behaviors
NCT02088047
UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
NCT02128230
MR Imaging Biomarkers of Disease Response to ECT (Electroconvulsive Therapy) in Depression
NCT02044289
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
NCT02012608
Implementation Trial of Evidence Based Practices for Mood Disorders
NCT02150577
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence
NCT02034201
Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues
NCT01968863
Is a Smartphone Application Effective as an Oral Medication Adherence Aid
NCT01968876
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
NCT02035189
Improving Buprenorphine Detoxification Outcomes With Isradipine
NCT01895270
A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women
NCT01877564
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
NCT02026609
UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma
NCT01884688
Transcranial Direct Current Stimulation for Improving Gait Training in Stroke
NCT01807637
Does Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) Reduce Heelstick Pain in Infants?
NCT01800318
Sutures vs. Staples Skin Closure After C-section in Obese Patients
NCT01820221
Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?
NCT01660412
A Phase I Clinical Trial of an HPV Therapeutic Vaccine
NCT01653249
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
NCT01632020
Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis
NCT01401439
Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia
NCT01620086
Weight Loss and Maintenance for Rural, African American Communities of Faith (The WORD)
NCT02169947
Mitochondrial Dysfunction in Phelan-McDermid Syndrome
NCT02000167
Etiology and Early Diagnosis of Neurodevelopmental Disorders
NCT02003170
Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling
NCT01964794
A Folinic Acid Intervention for Autism Spectrum Disorders
NCT01602016
Walnut Oral Immunotherapy for Tree Nut Allergy
NCT01546753
Clinical Efficacy of Atomoxetine for Methamphetamine Dependence
NCT01557569
A Lifestyle Physical Activity Intervention for Older Sedentary Women
NCT01707693
Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
NCT01449539
Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
NCT01537315
Safety of Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) in Infants
NCT01495286
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 62 |
| Phase 3 | 13 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the University of Arkansas pipeline
37 recruiting of 318 indexed (12% open); 202 completed (64%).
Phase mix: 17 late (III/IV) vs 102 early (I/II) (early-phase heavy).
Top condition: Multiple Myeloma (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Arkansas: open-pipeline peers nationwide
Peers matched on 318 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
University of Arkansas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 318 trials (± recruiting share)
- Rush University Medical Center · 320 trials · 17% recruiting
- Jonsson Comprehensive Cancer Center · 321 trials · 19% recruiting
- Allergan · 314 trials · 0% recruiting
- Celgene · 308 trials · 4% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Jazz Pharmaceuticals · 12% recruiting · 128 trials
- Abbott Diabetes Care · 12% recruiting · 26 trials
- Medtronic Vascular · 12% recruiting · 26 trials
- Midwest Center for Metabolic and Cardiovascular Research · 12% recruiting · 26 trials
Related
What to do with this University of Arkansas page
318 registered trials is a research-attention snapshot, not an endorsement of University of Arkansas or any single study.
- 37 of University of Arkansas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Myeloma is the condition University of Arkansas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Myeloma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Arkansas pipeline card: 318 registered trials from official public datasets.Report a data error.